Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-12-23
2008-08-12
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S504000
Reexamination Certificate
active
07410963
ABSTRACT:
The invention relates to compounds having PDE2 inhibitory activities, as well as therapeutic methods by administering said compounds, in particular for treating various diseases of the central or peripheral nervous system. It further deals with pharmaceutical compositions comprising said compounds and methods for preparing said compounds.
REFERENCES:
patent: 02/088096 (2002-11-01), None
patent: 02/098865 (2002-12-01), None
International Search Report of PCT/IB2004/004362, mailed May 4, 2005.
Abarghaz Mustapha
Biondi Stefano
Duranton Jérôme
Limanton Emmanuelle
Mondadori Cesare
Kifle Bruck
VIA Pharmaceuticals, Inc.
LandOfFree
Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4006392